DCT and hybrid studies enabled by our platform
Emerging Biopharma/biotech companies
of the top CROs as partners
Designed by experts at Medable who’ve conducted over 300+ hybrid trials, this course will give you:
The ability to apply the key elements and best practices of hybrid trials to your upcoming studies
An understanding how to reduce site burden, increase patient engagement and enrollment, and apply hybrid designs to reduce costs, and
A verified Digital Certification to post on your LinkedIn.
Available for free for a limited time only.
Musaddiq Khan
Vice President, Therapeutic Area Solutions
Andrew Mackinnon
Vice President and GM, Total Consent
Joe Dustin
Vice President and GM, eCOA
Florence Mowlem, PhD
Senior Director, eCOA Science & Solutions
Emerging biotech and biopharma are at the heart of innovation in drug development. At Medable, we recognize that smaller companies don’t always have a full team of experts in-house, which is why we have a team of experts specializing in all aspects of the clinical development process to support your needs.